Autonomic snags $20M to treat headaches
Autonomic Technologies, maker of implantable devices that can soothe severe headaches, has raised $20 million in a second round of funding led by InterWest Partners. The Menlo Park, Calif. company is one of three biotech firms InterWest has recently backed, including antiviral creator Eiger BioPharmaceuticals and autoimmune drug maker Lycera.
Previously, Autonomic raised a $5 million first round of capital from Kleiner Perkins Caufield & Byers and the Cleveland Clinic.
Next Story: Blogger analytics startup Whos.Amung.Us goes pro
Previous Story: SVTC Technologies raises $34 million for chip-making services
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.